Challenges and Solutions in pgRNA Measurement: Toward Improved Monitoring of Hepatitis B Therapy
Pathogens · 2026
DOI: 10.3390/pathogens15020153 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2026. Verfasst von Zhenkun Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Third Clinical Medical College of Ningxia Medical University, People's Hospital of Ningxia Hui Autonomous…. Hauptthemen laut MEDLINE: RNA, Viral, Hepatitis B virus, Virus Replication, Hepatitis B, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Interdisciplinary Construction Program of the College of Laboratory Medicine at Ningxia Medical University, The Natural Science Foundation of Ningxia Hui Autonomous Region, Interdisciplinary Construction Program of the College of Laboratory Medicine at Ningxia Medical University.
Abstract (Originalsprache)
Hepatitis B virus (HBV) pregenomic RNA (pgRNA), transcribed directly from nuclear covalently closed circular DNA (cccDNA), is an essential component in viral replication. The synthesis and encapsidation of pgRNA depend significantly on the transcriptional activity of cccDNA, making serum pgRNA a recently recognized non-invasive biomarker for evaluating cccDNA activity. However, its clinical application is limited by factors including preanalytical variables, methodological inconsistencies in detection, and a lack of standardization in quantification. This review provides an overview of the biological origins of pgRNA and its critical role in the HBV replication cycle, highlighting the stability challenges encountered during the collection, processing, and storage of plasma/serum samples. Furthermore, it analyzes recent significant advancements in pgRNA detection technologies, encompassing modified reverse transcription quantitative polymerase chain reaction (RT-qPCR), nucleocapsid-captured methodologies, automated testing platforms, multiplex digital PCR, isothermal amplification, and clustered regularly interspaced short palindromic repeats-based assays. A comparison of these technologies revealed that discrepancies in pgRNA quantification arise primarily from variations in sample processing and measurement systems, rather than from inherent biological limitations. Therefore, establishing standardized sample handling procedures, harmonized detection methods, and unified measurement systems is imperative before pgRNA can be reliably applied to monitor treatment, guide cessation decisions, or evaluate cure in chronic hepatitis B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Third Clinical Medical College of Ningxia Medical University, People's Hospital of Ningxia Hui Autonomous Region, No. 255 Zhengyuan North Street, Jinfeng District, Yinchuan 75…
- Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China.
ORCID-Profile: Zhenkun Zhu, Tao Wu
Förderung
- The Interdisciplinary Construction Program of the College of Laboratory Medicine at Ningxia Medical University
- The Natural Science Foundation of Ningxia Hui Autonomous Region
- Interdisciplinary Construction Program of the College of Laboratory Medicine at Ningxia Medical University
- Natural Science Foundation of Ningxia Hui Autonomous Region
Zitieren
APA
Zhu, Z., Wu, J., Li, J., & Wu, T. (2026). Challenges and Solutions in pgRNA Measurement: Toward Improved Monitoring of Hepatitis B Therapy. Pathogens. https://doi.org/10.3390/pathogens15020153
Vancouver
Zhu Z, Wu J, Li J, Wu T. Challenges and Solutions in pgRNA Measurement: Toward Improved Monitoring of Hepatitis B Therapy. Pathogens. 2026. doi:10.3390/pathogens15020153
BibTeX
@article{Zhu2026,
author = {Zhu, Zhenkun and Wu, Jin and Li, Jinyuan and Wu, Tao},
title = {Challenges and Solutions in pgRNA Measurement: Toward Improved Monitoring of Hepatitis B Therapy},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15020153}
}
EUVIMED